《BLING III研究的统计分析计划勘误：一项关于脓毒症重症患者连续与间歇β-内酰胺类抗生素输注的3期多中心随机对照试验》[《重症监护与复苏》23(3) (2021) 273 - 284]
Corrigendum to "Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis" [Crit Care Resusc 23(3) (2021) 273-284].
作者信息
Billot Laurent, Lipman Jeffrey, Brett Stephen J, De Waele Jan J, Cotta Menino Osbert, Davis Joshua S, Finfer Simon, Hammond Naomi, Knowles Serena, McGuinness Shay, Myburgh John, Paterson David L, Peake Sandra, Rajbhandari Dorrilyn, Rhodes Andrew, Roberts Jason A, Roger Claire, Shirwadkar Charudatt, Starr Therese, Taylor Colman, Dulhunty Joel M
机构信息
The George Institute for Global Health, Sydney, NSW, Australia.
Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
出版信息
Crit Care Resusc. 2023 May 20;25(1):60. doi: 10.1016/j.ccrj.2023.04.012. eCollection 2023 Mar.
Abstract
[This corrects the article DOI: 10.51893/2021.3.oa4.].
摘要
[本文更正了文章的数字对象标识符：10.51893/2021.3.oa4。]
相似文献
1
Corrigendum to "Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis" [Crit Care Resusc 23(3) (2021) 273-284].《BLING III研究的统计分析计划勘误：一项关于脓毒症重症患者连续与间歇β-内酰胺类抗生素输注的3期多中心随机对照试验》[《重症监护与复苏》23(3) (2021) 273 - 284]
Crit Care Resusc. 2023 May 20;25(1):60. doi: 10.1016/j.ccrj.2023.04.012. eCollection 2023 Mar.
2
Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis.BLING III研究的统计分析计划：一项针对脓毒症重症患者连续与间歇β-内酰胺类抗生素输注的3期多中心随机对照试验。
Crit Care Resusc. 2023 Oct 18;23(3):273-284. doi: 10.51893/2021.3.OA4. eCollection 2021 Sep 6.
3
4
A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study.一项多中心随机对照试验方案，比较连续β-内酰胺输注与重症脓毒症患者间歇性β-内酰胺给药：BLING II 研究。
Crit Care Resusc. 2013 Sep;15(3):179-85.
5
Corrigendum to "Statistical analysis plan for the biomarker-guided intervention to prevent acute kidney injury after major surgery (BigpAK-2) study: An international randomised controlled multicentre trial" Crit Care Resusc. 26(2) (2024) 80-86. eCollection 2024 Jun.《生物标志物引导干预预防大手术后急性肾损伤（BigpAK - 2）研究的统计分析计划：一项国际随机对照多中心试验》勘误 危重病急救复苏杂志。2024年第26卷第2期，第80 - 86页。2024年6月电子期刊。
Crit Care Resusc. 2024 Sep 12;26(3):223. doi: 10.1016/j.ccrj.2024.09.001. eCollection 2024 Sep.
6
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.严重脓毒症的β-内酰胺输注（BLISS）：一项前瞻性、双中心、开放标签随机对照试验，比较了连续性与间歇性β-内酰胺输注在重症严重脓毒症患者中的应用。
Intensive Care Med. 2016 Oct;42(10):1535-1545. doi: 10.1007/s00134-015-4188-0. Epub 2016 Jan 11.
7
Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials.严重脓毒症中连续与间断β-内酰胺输注的比较。来自随机试验的个体患者数据的荟萃分析。
Am J Respir Crit Care Med. 2016 Sep 15;194(6):681-91. doi: 10.1164/rccm.201601-0024OC.
8
Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial.连续或间断输注β-内酰胺类抗生素治疗患者中增强的肾清除率与临床结局的关系：BLING-II 随机、安慰剂对照临床试验的嵌套队列研究。
Int J Antimicrob Agents. 2017 May;49(5):624-630. doi: 10.1016/j.ijantimicag.2016.12.022. Epub 2017 Mar 9.
9
A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.严重脓毒症中连续与间断β-内酰胺输注的多中心随机试验。
Am J Respir Crit Care Med. 2015 Dec 1;192(11):1298-305. doi: 10.1164/rccm.201505-0857OC.
10
Should β-lactam antibiotics be administered by continuous infusion in critically ill patients? A survey of Australia and New Zealand intensive care unit doctors and pharmacists.β-内酰胺类抗生素是否应在危重症患者中持续输注？对澳大利亚和新西兰重症监护病房医生和药剂师的调查。
Int J Antimicrob Agents. 2016 Jun;47(6):436-8. doi: 10.1016/j.ijantimicag.2016.02.017. Epub 2016 Apr 25.
Zotero 插件